Fate Therapeutics Inc (FATE)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current FATE market cap is 181.1M. The company's latest EPS is USD -1.4130 and P/E is -1.14.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.94M | 1.68M | 1.93M | 6.77M | 3.07M |
| Operating Income | -51.28M | -48.08M | -51.07M | -45.08M | -52.38M |
| Net Income | -45.17M | -44.12M | -48M | -38.43M | -47.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 10.68M | 31.43M | 55.85M | 96.3M | 63.53M |
| Operating Income | -100.73M | -128.09M | -216.99M | -308.39M | -190.51M |
| Net Income | -98.15M | -173.39M | -212.15M | -281.72M | -160.93M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 543.79M | 506.22M | 569.89M | 528.82M | 494.97M |
| Total Liabilities | 141.01M | 137.8M | 143.78M | 131.84M | 132.64M |
| Total Equity | 402.78M | 368.42M | 426.12M | 396.98M | 362.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 302.27M | 622.46M | 921.46M | 705.56M | 506.22M |
| Total Liabilities | 57.52M | 238.01M | 242.62M | 221.62M | 137.8M |
| Total Equity | 244.76M | 384.45M | 678.84M | 483.94M | 368.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -95.63M | -132.26M | -33.35M | -65.66M | -95.08M |
| Investing | 67.31M | 112.67M | 17.31M | -36.06M | -10.6M |
| Financing | 265k | 85k | 95.49M | 96.76M | 96.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -83.18M | -39.23M | -162.87M | -248.21M | -132.26M |
| Investing | -157.45M | -161.08M | -324.02M | 166.75M | 112.67M |
| Financing | 149.93M | 282.84M | 453.13M | 9.21M | 85k |
| Market Cap | 181.1M |
| Price to Earnings Ratio | -1.14 |
| Price to Sales Ratio | 2.89 |
| Price to Cash Ratio | 4.38 |
| Price to Book Ratio | 0.5 |
| Dividend Yield | - |
| Shares Outstanding | 113.89M |
| Average Volume (1 week) | 2.01M |
| Average Volume (1 Month) | 3.58M |
| 52 Week Change | -56.55% |
| 52 Week High | 8.83 |
| 52 Week Low | 1.56 |
| Spread (Intraday) | 0.06 (3.64%) |
| Company Name | Fate Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.fatetherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
